Intimate care products require careful formulation. The safety of an intimate care product is not only about whether each individual ingredient is considered safe. The complete formulation, including its effect on the vaginal microbiome, pH, osmolality and potential irritation, needs to be considered. The vaginal environment is different from other areas of the body, so products need to be developed with these specific conditions in mind.
Looking beyond individual ingredients
The vaginal microbiome plays an important role in maintaining the natural environment. It contains microorganisms and bacteria that contribute to an acidic vaginal pH, normally between 3.8 and 4.5.
A formulation that does not take this environment into account may affect the natural balance of the microbiome. It can contribute to irritation or discomfort and may interfere with the normal protective environment.
For this reason, intimate care formulations require more than standard ingredient safety assessments. Microbiological considerations, appropriate safety evaluations and formulation knowledge all have a role in product development.
Why osmolality matters
Osmolality is another factor that needs attention in intimate care products. It refers to the concentration of dissolved chemical particles in a liquid.
Products with high osmolality can draw water out of mucosal cells. This may cause cellular stress and changes to the cell membrane. At higher levels, it can contribute to cell damage and tissue irritation.
These effects may be associated with dryness, irritation and inflammation. They can potentially increase susceptibility to sexually transmitted infections.
Some commonly used humectants can be hyperosmotic. Their ability to attract water can be useful for hydration, but the same mechanism can draw water from cells that are already hydrated.
The final formulation therefore matters. A product can be designed to have an osmolality that is closer to, or lower than, that of vaginal tissue. This can help reduce the potential effects associated with highly hyperosmotic formulations.
The vaginal microbiome needs consideration
Product development for intimate care should take the vaginal microbiome into account from the beginning. Testing can look at microbiological purity, microbial diversity and how a formulation affects the growth behaviour of microorganisms.
The balance between protective bacteria is particularly relevant. Laboratory testing can help assess whether an ingredient or finished formulation has a negative effect on this environment.
This does not mean that one ingredient automatically determines whether a product is suitable. The way ingredients are combined and used within the finished formulation remains an important part of the assessment.
The complete formulation matters
An ingredient may have useful properties, but its effect can change depending on the finished formulation. This is why intimate care products need to be assessed as complete systems rather than by looking at individual ingredients alone.
Humectants, solvents and other formulation components can influence characteristics such as skin feel, hydration, irritation and osmolality. The right balance depends on the intended product and its formulation requirements.
For intimate care, formulation safety is therefore closely connected to the environment in which the product will be used. Considering the vaginal microbiome, pH, osmolality and irritation alongside the properties of individual ingredients can help guide the development of suitable intimate care products.
